The French National Agency for the Safety of Medicines and Health Products (ANSM) has updated on 08/08/2022 its guidelines for the determination of financial penalties in case of non-compliance of pharmaceutical companies with the

Having a Business Continuity Plan (BCP) would have enabled many companies to cope much better with the crisis linked to the COVID-19.Indeed, the Business Continuity Plan (BCP) makes it possible to anticipate problems likely the di

The Qualified Person (QP) a key function in the French pharmaceutical companies The Qualified Person is a privileged function in France. Placed at the heart of the board of directors of the French pharmaceutica

AxeRegel is a regulatory and pharmaceutical affairs consultancy company based in France. We offer regulatory and pharmaceutical consulting services for the life sciences industry through the lifecycle of their products.W